To edit or not to edit: Regulation of ADAR editing specificity and efficiency

Wiley Interdisciplinary Reviews: RNA

Volumn 7, Issue 1, 2016, Pages 113-127

  Deffit, Sarah N ^a   Hundley, Heather A ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAR PROTEIN; ADAR1 PROTEIN; ADAR2 PROTEIN; ADAR3 PROTEIN; ADENOSINE DEAMINASE; AZIN1 PROTEIN; CELL PROTEIN; CIS ACTING ELEMENT; DOUBLE STRANDED DNA; DOUBLE STRANDED RNA; INOSINE; MESSENGER RNA; PROTEIN KINASE R; RNA BINDING PROTEIN; TRANS ACTING FACTOR; UNCLASSIFIED DRUG; VIRUS RNA; ADENOSINE;

AMINO ACID SUBSTITUTION; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENE FLOW; GENETIC REGULATION; HUMAN IMMUNODEFICIENCY VIRUS; INNATE IMMUNITY; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; RNA EDITING; UNTRANSLATED REGION; VIRUS IMMUNITY; ANIMAL; HUMAN; METABOLISM;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; HUMANS; INOSINE; RNA EDITING; RNA-BINDING PROTEINS;

EID: 84955464451     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.1319     Document Type: Review

References (127)

1. Maas S. RNA Editing: Current Research and Future Trends. Caister Academic Press: Portland OR; 2013, Pages viii, 240 pages.
2. Samuel CE. Adenosine deaminases acting on RNA (ADARs) and A-to-I editing. Curr Top Microbiol Immunol 2012, 353:238.
3. Wu JY. Posttranscriptional Gene Regulation RNA Processing in Eukaryotes. Wiley-Blackwell: Weinheim, Germany; 2013, Pages xvi, 260 pages.
4. Jackman JE, Alfonzo JD. Transfer RNA modifications: nature's combinatorial chemistry playground. WIREs RNA 2013, 4:35-48.
5. Wahlstedt H, Ohman M. Site-selective versus promiscuous A-to-I editing. WIREs RNA 2011, 2:761-771.
6. Wulff B, Nishikura K. Subsitutional A-to-I RNA editing. WIREs RNA 2010, 1:90-101.
7. Zinshteyn B, Nishikura K. Adenosine-to-inosine RNA editing. WIREs Sys Biol Med 2009, 1:202-209.
8. Gott JM, Emeson RB. Functions and mechanisms of RNA editing. Annu Rev Genet 2000, 34:499-531.
9. Bazak L, Haviv A, Barak M, Jacob-Hirsch J, Deng P, Zhang R, Isaacs FJ, Rechavi G, Li JB, Eisenberg E, et al. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res 2014, 24:365-376.
10. Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, Weiss MJ, Nishikura K. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 2004, 279:4952-4961.
11. Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N, Feldmeyer D, Sprengel R, Seeburg PH. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000, 406:78-81.
12. Palladino MJ, Keegan LP, O'Connell MA, Reenan RA. A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity. Cell 2000, 102:437-449.
13. Tonkin LA, Saccomanno L, Morse DP, Brodigan T, Krause M, Bass BL. RNA editing by ADARs is important for normal behavior in Caenorhabditis elegans. EMBO J 2002, 21:6025-6035.
14. Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 2006, 311:230-232.
15. Gaisler-Salomon I, Kravitz E, Feiler Y, Safran M, Biegon A, Amariglio N, Rechavi G. Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease. Neurobiol Aging 2014, 35:1785-91.
16. Kwak S, Kawahara Y. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. J Mol Med 2005, 83:110-120.
17. Maas S, Patt S, Schrey M, Rich A. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci USA 2001, 98:14687-14692.
18. Han SW, Kim HP, Shin JY, Jeong EG, Lee WC, Kim KY, Park SY, Lee DW, Won JK, Jeong SY, et al. RNA editing in RHOQ promotes invasion potential in colorectal cancer. J Exp Med 2014, 211:613-621.
19. Qin YR, Qiao JJ, Chan TH, Zhu YH, Li FF, Liu H, Fei J, Li Y, Guan XY, Chen L. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma. Cancer Res 2014, 74:840-851.
20. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 2010, 79:321-349.
21. Goodman RA, Macbeth MR, Beal PA. ADAR proteins: structure and catalytic mechanism. Curr Top Microbiol Immunol 2012, 353:1-33.
22. Hundley HA, Bass BL. ADAR editing in double-stranded UTRs and other noncoding RNA sequences. Trends Biochem Sci 2010, 35:377-383.
23. Tomaselli S, Bonamassa B, Alisi A, Nobili V, Locatelli F, Gallo A. ADAR enzyme and miRNA story: a nucleotide that can make the difference. Int J Mol Sci 2013, 14:22796-22816.
24. Samuel CE. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology 2011, 411:180-93.
25. Rosenthal JJ, Seeburg PH. A-to-I RNA editing: effects on proteins key to neural excitability. Neuron 2012, 74:432-439.
26. Cenci C, Barzotti R, Galeano F, Corbelli S, Rota R, Massimi L, Di Rocco C, O'Connell MA, Gallo A. Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem 2008, 283:7251-7260.
27. Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada N, Hagimura N, Okado H, Miwa A, Kurihara H, Nakazato Y, Tamura M, et al. Blockage of Ca (2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 2002, 8:971-978.
28. Shimokawa T, Rahman MF, Tostar U, Sonkoly E, Stahle M, Pivarcsi A, Palaniswamy R, Zaphiropoulos PG. RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling. RNA Biol 2013, 10:321-333.
29. Chen L, Li Y, Lin CH, Chan TH, Chow RK, Song Y, Liu M, Yuan YF, Fu L, Kong KL, et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 2013, 19:209-216.
30. Xu G, Zhang J. Human coding RNA editing is generally nonadaptive. Proc Natl Acad Sci USA 2014, 111:3769-3774.
31. Beghini A, Ripamonti CB, Peterlongo P, Roversi G, Cairoli R, Morra E, Larizza L. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum Mol Genet 2000, 9:2297-2304.
32. Ivanov A, Memczak S, Wyler E, Torti F, Porath HT, Orejuela MR, Piechotta M, Levanon EY, Landthaler M, Dieterich C, et al. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep 2015, 10:170-177.
33. Rybak-Wolf A, Stottmeister C, Glazar P, Jens M, Pino N, Giusti S, Hanan M, Behm M, Bartok O, Ashwal-Fluss R, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell 2015, 58:870-885.
34. Paul MS, Bass BL. Inosine exists in mRNA at tissue-specific levels and is most abundant in brain mRNA. EMBO J 1998, 17:1120-1127.
35. Li JB, Church GM. Deciphering the functions and regulation of brain-enriched A-to-I RNA editing. Nat Neurosci 2013, 16:1518-1522.
36. Wang Q, Hui H, Guo Z, Zhang W, Hu Y, He T, Tai Y, Peng P, Wang L. ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding. RNA 2013, 19:1525-1536.
37. Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, Nishikura K. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 2007, 315:1137-1140.
38. Raser JM, O'Shea EK. Noise in gene expression: origins, consequences, and control. Science 2005, 309:2010-2013.
39. Ulbricht RJ, Emeson RB. One hundred million adenosine-to-inosine RNA editing sites: hearing through the noise. Bioessays 2014, 36:730-735.
40. Pinto Y, Cohen HY, Levanon EY. Mammalian conserved ADAR targets comprise only a small fragment of the human editosome. Genome Biol 2014, 15:R5.
41. Tariq A, Garncarz W, Handl C, Balik A, Pusch O, Jantsch MF. RNA-interacting proteins act as site-specific repressors of ADAR2-mediated RNA editing and fluctuate upon neuronal stimulation. Nucleic Acids Res 2013, 41:2581-2593.
42. Washburn MC, Kakaradov B, Sundararaman B, Wheeler E, Hoon S, Yeo GW, Hundley HA. The dsRBP and inactive editor ADR-1 utilizes dsRNA binding to regulate A-to-I RNA editing across the C. elegans transcriptome. Cell Rep 2014, 6:599-607.
43. Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M, Hirschberg A, et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res 2007, 17:1586-1595.
44. Tomaselli S, Galeano F, Locatelli F, Gallo A. ADARs and the balance game between virus infection and innate immune cell response. Curr Issues Mol Biol 2015, 17:37-52.
45. Zahn RC, Schelp I, Utermohlen O, von Laer D. A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus. J Virol 2007, 81:457-464.
46. Doria M, Neri F, Gallo A, Farace MG, Michienzi A. Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res 2009, 37:5848-5858.
47. Hartner JC, Walkley CR, Lu J, Orkin SH. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol 2009, 10:109-115.
48. Liddicoat BJ, Piskol R, Chalk AM, Ramaswami G, Higuchi M, Hartner JC, Li JB, Seeburg PH, Walkley CR. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 2015, 349:1115-1120.
49. Mannion NM, Greenwood SM, Young R, Cox S, Brindle J, Read D, Nellaker C, Vesely C, Ponting CP, McLaughlin PJ, et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep 2014, 9:1482-1494.
50. Chen CX, Cho DS, Wang Q, Lai F, Carter KC, Nishikura K. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 2000, 6:755-767.
51. Patterson JB, Samuel CE. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol 1995, 15:5376-5388.
52. Fritz J, Strehblow A, Taschner A, Schopoff S, Pasierbek P, Jantsch MF. RNA-regulated interaction of transportin-1 and exportin-5 with the double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling of ADAR1. Mol Cell Biol 2009, 29:1487-1497.
53. Strehblow A, Hallegger M, Jantsch MF. Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain. Mol Biol Cell 2002, 13:3822-3835.
54. Bratt E, Ohman M. Coordination of editing and splicing of glutamate receptor pre-mRNA. RNA 2003, 9:309-318.
55. Chen L. Characterization and comparison of human nuclear and cytosolic editomes. Proc Natl Acad Sci U S A 2013, 110:E2741-E2747.
56. Sansam CL, Wells KS, Emeson RB. Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc Natl Acad Sci USA 2003, 100:14018-14023.
57. Desterro JM, Keegan LP, Lafarga M, Berciano MT, O'Connell M, Carmo-Fonseca M. Dynamic association of RNA-editing enzymes with the nucleolus. J Cell Sci 2003, 116:1805-1818.
58. Marcucci R, Brindle J, Paro S, Casadio A, Hempel S, Morrice N, Bisso A, Keegan LP, Del Sal G, O'Connell MA. Pin1 and WWP2 regulate GluR2 Q/R site RNA editing by ADAR2 with opposing effects. EMBO J 2011, 30:4211-4222.
59. Lai F, Chen CX, Carter KC, Nishikura K. Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases. Mol Cell Biol 1997, 17:2413-2424.
60. Gerber A, O'Connell MA, Keller W. Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. RNA 1997, 3:453-463.
61. Li Z, Tian Y, Tian N, Zhao X, Du C, Han L, Zhang H. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma. Oncol Rep 2015, 33:2845-2852.
62. Rueter SM, Dawson TR, Emeson RB. Regulation of alternative splicing by RNA editing. Nature 1999, 399:75-80.
63. Gan Z, Zhao L, Yang L, Huang P, Zhao F, Li W, Liu Y. RNA editing by ADAR2 is metabolically regulated in pancreatic islets and β-cells. J Biol Chem 2006, 281:33386-33394.
64. Melcher T, Maas S, Herb A, Sprengel R, Higuchi M, Seeburg PH. RED2, a brain-specific member of the RNA-specific adenosine deaminase family. J Biol Chem 1996, 271:31795-31798.
65. Klaue Y, Kallman AM, Bonin M, Nellen W, Ohman M. Biochemical analysis and scanning force microscopy reveal productive and nonproductive ADAR2 binding to RNA substrates. RNA 2003, 9:839-846.
66. Kallman AM, Sahlin M, Ohman M. ADAR2 A→I editing: site selectivity and editing efficiency are separate events. Nucleic Acids Res 2003, 31:4874-4881.
67. Heale BS, Keegan LP, McGurk L, Michlewski G, Brindle J, Stanton CM, Caceres JF, O'Connell MA. Editing independent effects of ADARs on the miRNA/siRNA pathways. EMBO J 2009, 28:3145-3156.
68. Ota H, Sakurai M, Gupta R, Valente L, Wulff BE, Ariyoshi K, Iizasa H, Davuluri RV, Nishikura K. ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell 2013, 153:575-589.
69. Warf MB, Shepherd BA, Johnson WE, Bass BL. Effects of ADARs on small RNA processing pathways in C. elegans. Genome Res 2012, 22:1488-1498.
70. Barraud P, Allain FH. ADAR proteins: double-stranded RNA and Z-DNA binding domains. Curr Top Microbiol Immunol 2012, 353:35-60.
71. Liu Y, Lei M, Samuel CE. Chimeric double-stranded RNA-specific adenosine deaminase ADAR1 proteins reveal functional selectivity of double-stranded RNA-binding domains from ADAR1 and protein kinase PKR. Proc Natl Acad Sci USA 2000, 97:12541-12546.
72. Xu M, Wells KS, Emeson RB. Substrate-dependent contribution of double-stranded RNA-binding motifs to ADAR2 function. Mol Biol Cell 2006, 17:3211-3220.
73. Ohman M, Kallman AM, Bass BL. In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R/G site. RNA 2000, 6:687-697.
74. Lehmann KA, Bass BL. The importance of internal loops within RNA substrates of ADAR1. J Mol Biol 1999, 291:1-13.
75. Stefl R, Oberstrass FC, Hood JL, Jourdan M, Zimmermann M, Skrisovska L, Maris C, Peng L, Hofr C, Emeson RB, et al. The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove. Cell 2010, 143:225-237.
76. Stefl R, Xu M, Skrisovska L, Emeson RB, Allain FH. Structure and specific RNA binding of ADAR2 double-stranded RNA binding motifs. Structure 2006, 14:345-355.
77. Stephens OM, Haudenschild BL, Beal PA. The binding selectivity of ADAR2's dsRBMs contributes to RNA-editing selectivity. Chem Biol 2004, 11:1239-1250.
78. Daniel C, Silberberg G, Behm M, Ohman M. Alu elements shape the primate transcriptome by cis-regulation of RNA editing. Genome Biol 2014, 15:R28.
79. Daniel C, Veno MT, Ekdahl Y, Kjems J, Ohman M. A distant cis acting intronic element induces site-selective RNA editing. Nucleic Acids Res 2012, 40:9876-9886.
80. Daniel C, Lagergren J, Ohman M. RNA editing of non-coding RNA and its role in gene regulation. Biochimie 2015, 40:180-93.
81. Feng Y, Baig TT, Love RP, Chelico L. Suppression of APOBEC3-mediated restriction of HIV-1 by Vif. Front Microbiol 2014, 5:450.
82. Wang X, Vukovic L, Koh HR, Schulten K, Myong S. Dynamic profiling of double-stranded RNA binding proteins. Nucleic Acids Res 2015, 43:7566-76.
83. Koh HR, Kidwell MA, Ragunathan K, Doudna JA, Myong S. ATP-independent diffusion of double-stranded RNA binding proteins. Proc Natl Acad Sci USA 2013, 110:151-156.
84. Polson AG, Bass BL. Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase. EMBO J 1994, 13:5701-5711.
85. St Laurent G, Tackett MR, Nechkin S, Shtokalo D, Antonets D, Savva YA, Maloney R, Kapranov P, Lawrence CE, Reenan RA. Genome-wide analysis of A-to-I RNA editing by single-molecule sequencing in Drosophila. Nat Struct Mol Biol 2013, 20:1333-1339.
86. Wheeler EC, Washburn MC, Major F, Rusch DB, Hundley HA. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript. RNA Biol 2015, 12:162-174.
87. Lehmann KA, Bass BL. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 2000, 39:12875-12884.
88. Riedmann EM, Schopoff S, Hartner JC, Jantsch MF. Specificity of ADAR-mediated RNA editing in newly identified targets. RNA 2008, 14:1110-1118.
89. Wong SK, Sato S, Lazinski DW. Substrate recognition by ADAR1 and ADAR2. RNA 2001, 7:846-858.
90. Kuttan A, Bass BL. Mechanistic insights into editing-site specificity of ADARs. Proc Natl Acad Sci USA 2012, 109:E3295-E3304.
91. Eifler T, Pokharel S, Beal PA. RNA-Seq analysis identifies a novel set of editing substrates for human ADAR2 present in Saccharomyces cerevisiae. Biochemistry 2013, 52:7857-7869.
92. Phelps KJ, Tran K, Eifler T, Erickson AI, Fisher AJ, Beal PA. Recognition of duplex RNA by the deaminase domain of the RNA editing enzyme ADAR2. Nucleic Acids Res 2015, 43:1123-1132.
93. Eggington JM, Greene T, Bass BL. Predicting sites of ADAR editing in double-stranded RNA. Nat Commun 2011, 2:319.
94. Palavicini JP, Correa-Rojas RA, Rosenthal JJ. Extra double-stranded RNA binding domain (dsRBD) in a squid RNA editing enzyme confers resistance to high salt environment. J Biol Chem 2012, 287:17754-17764.
95. Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D, et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol 2004, 22:1001-1005.
96. Maas S, Melcher T, Herb A, Seeburg PH, Keller W, Krause S, Higuchi M, O'Connell MA. Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase. J Biol Chem 1996, 271:12221-12226.
97. Rieder LE, Staber CJ, Hoopengardner B, Reenan RA. Tertiary structural elements determine the extent and specificity of messenger RNA editing. Nat Commun 2013, 4:2232.
98. Nishikura K, Yoo C, Kim U, Murray JM, Estes PA, Cash FE, Liebhaber SA. Substrate specificity of the dsRNA unwinding/modifying activity. EMBO J 1991, 10:3523-3532.
99. Polson AG, Bass BL. Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase. EMBO J 1994, 13:5701-5711.
100. Greenberger S, Levanon EY, Paz-Yaacov N, Barzilai A, Safran M, Osenberg S, Amariglio N, Rechavi G, Eisenberg E. Consistent levels of A-to-I RNA editing across individuals in coding sequences and non-conserved Alu repeats. BMC Genomics 2010, 11:608.
101. Nishikura K, Yoo C, Kim U, Murray JM, Estes PA, Cash FE, Liebhaber SA. Substrate specificity of the dsRNA unwinding/modifying activity. EMBO J 1991, 10:3523-3532.
102. Bass BL, Weintraub H. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 1988, 55:1089-1098.
103. Carmi S, Borukhov I, Levanon EY. Identification of widespread ultra-edited human RNAs. PLoS Genet 2011, 7:e1002317.
104. Porath HT, Carmi S, Levanon EY. A genome-wide map of hyper-edited RNA reveals numerous new sites. Nat Commun 2014, 5:4726.
105. Alon S, Garrett SC, Levanon EY, Olson S, Graveley BR, Rosenthal JJ, Eisenberg E. The majority of transcripts in the squid nervous system are extensively recoded by A-to-I RNA editing. Elife 2015, 4.
106. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997, 387:303-308.
107. Rosenthal JJ. The emerging role of RNA editing in plasticity. J Exp Biol 2015, 218:1812-1821.
108. Garrett S, Rosenthal JJ. RNA editing underlies temperature adaptation in K+ channels from polar octopuses. Science 2012, 335:848-851.
109. Rieder LE, Savva YA, Reyna MA, Chang YJ, Dorsky JS, Rezaei A, Reenan RA. Dynamic response of RNA editing to temperature in Drosophila. BMC Biol 2015, 13:1.
110. Bass BL, Weintraub H. A developmentally regulated activity that unwinds RNA duplexes. Cell 1987, 48:607-613.
111. Wahlstedt H, Daniel C, Enstero M, Ohman M. Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. Genome Res 2009, 19:978-986.
112. Shtrichman R, Germanguz I, Mandel R, Ziskind A, Nahor I, Safran M, Osenberg S, Sherf O, Rechavi G, Itskovitz-Eldor J. Altered A-to-I RNA editing in human embryogenesis. PLoS One 2012, 7:e41576.
113. Veno MT, Bramsen JB, Bendixen C, Panitz F, Holm IE, Ohman M, Kjems J. Spatio-temporal regulation of ADAR editing during development in porcine neural tissues. RNA Biol 2012, 9:1054-1065.
114. Chen JY, Peng Z, Zhang R, Yang XZ, Tan BC, Fang H, Liu CJ, Shi M, Ye ZQ, Zhang YE, et al. RNA editome in rhesus macaque shaped by purifying selection. PLoS Genet 2014, 10:e1004274.
115. Agranat L, Sperling J, Sperling R. A novel tissue-specific alternatively spliced form of the A-to-I RNA editing enzyme ADAR2. RNA Biol 2010, 7:253-262.
116. Jaikaran DC, Collins CH, MacMillan AM. Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site. J Biol Chem 2002, 277:37624-37629.
117. Hough RF, Bass BL. Purification of the Xenopus laevis double-stranded RNA adenosine deaminase. J Biol Chem 1994, 269:9933-9939.
118. Valente L, Nishikura K. RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions. J Biol Chem 2007, 282:16054-16061.
119. Wang Q, O'Brien PJ, Chen CX, Cho DS, Murray JM, Nishikura K. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem 2000, 74:1290-1300.
120. Gerber AP, Keller W. An adenosine deaminase that generates inosine at the wobble position of tRNAs. Science 1999, 286:1146-1149.
121. 2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci 2007, 27:7987-8001.
122. Stulic M, Jantsch MF. Spatio-temporal profiling of Filamin A RNA-editing reveals ADAR preferences and high editing levels outside neuronal tissues. RNA Biol 2013, 10:1611-7.
123. Sharmeen L, Bass B, Sonenberg N, Weintraub H, Groudine M. Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. Proc Natl Acad Sci USA 1991, 88:8096-8100.
124. Polson AG, Ley HL 3rd, Bass BL, Casey JL. Hepatitis delta virus RNA editing is highly specific for the amber/W site and is suppressed by hepatitis delta antigen. Mol Cell Biol 1998, 18:1919-1926.
125. Vitali P, Basyuk E, Le Meur E, Bertrand E, Muscatelli F, Cavaille J, Huttenhofer A. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs. J Cell Biol 2005, 169:745-753.
126. Yi-Brunozzi HY, Easterwood LM, Kamilar GM, Beal PA. Synthetic substrate analogs for the RNA-editing adenosine deaminase ADAR-2. Nucleic Acids Res 1999, 27:2912-2917.
127. Morabito MV, Abbas AI, Hood JL, Kesterson RA, Jacobs MM, Kump DS, Hachey DL, Roth BL, Emeson RB. Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol Dis 2010, 39:169-180.